Please login to the form below

Not currently logged in

Janssen’s Leisha Daly appointed VP of IPHA

Joins Irish trade body for pharma as plan to cut country’s drug prices agreed

Leisha Daly, IPHAThe Irish Pharmaceutical Healthcare Association (IPHA) has appointed Janssen's Dr Leisha Daly as vice president.

Dr Daly, who serves as country director at Janssen, joins the trade body at a crucial time for the pharma industry in Ireland, with the IPHA this week agreeing plans with the Department of Health and Health Service Executive (HSE) to cut the price of hundreds of medicines by an average of 10 per cent.

She takes over from Pfizer's David Gallagher as vice president, following his two years in the position, and will serve alongside fellow vice president Dr Neil Boyle of MSD.

In addition to her role at Janssen, Dr Daly has served on the IPHA board of directors since June, 2012, and was appointed to the prescription medicines division strategy board in August, 2012.

Dr Daly joined Janssen in 1998 as head of technical affairs, rising up the ranks to hold a variety of senior positions in medical, sales and marketing, before being appointed to her current position in March, 2012.

Prior to joining Janssen, Dr Daly served at Hoechst Ireland having spent several years in academic clinical research.

25th October 2012

From: Research, Sales, Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...